Developed in partnership with the Joint Commission International for Patient Safety
BD (Becton, Dickinson and Company), a global medical technology company, has launched a new patient safety program for hospitals, called Preventing Risks of Infections and Medication Errors in IV Therapy (PRIME).
PRIME is developed by Joint Commission International for Patient Safety, with sponsorship by BD, to address the top two challenges in a hospital setting - infection prevention and medication safety.
A unique programmatic approach towards patient safety will be implemented over a six-month duration, composed of goal-setting, constant progress review, tele-consultations with experts and scientific updates through webinars. Hospitals will be certified upon successful completion of the program.
PRIME is officially launched in the following countries: South Korea, Japan, Malaysia, Thailand, Indonesia, Philippines, Vietnam and India. To date, 21 leading hospitals have signed up for the program.
Click here for the complete issue.